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MinD is a ubiquitous ATPase that plays a crucial role
in selection of the division site in eubacteria, chloro-
plasts, and probably also Archaea. It was recently dem-
onstrated that membrane localization of MinD is medi-
ated by an 8–12-residue C-terminal motif termed the
membrane targeting sequence or MTS. In this study we
show that the MinD MTS is a transplantable lipid-bind-
ing motif that can effectively target heterologous pro-
teins to the cell membrane. We demonstrate that eubac-
terial MTSs interact directly with lipid bilayers as an
amphipathic helix, with a distinct preference for ani-
onic phospholipids. Moreover, we provide evidence that
the phospholipid preference of each MTS, as well as its
affinity for biological membranes, has been evolutionar-
ily “tuned” to its specific role in different bacteria. We
propose a model to describe how the MTS is coupled to
ATP binding to regulate the reversible membrane asso-
ciation of Escherichia coli MinD during its pole-to-pole
oscillation cycle.
The initiating event in bacterial cytokinesis is the formation
of a circumferential ring of polymerized FtsZ, the ancestral
homolog of eukaryotic tubulin (1–3). The FtsZ ring provides a
scaffold onto which numerous proteins are subsequently as-
sembled to form the functional division apparatus (4, 5). In the
rod-shaped bacterium Escherichia coli, placement of the FtsZ
ring, and thus the division septum, is negatively regulated by
the three proteins encoded by the minB operon: MinC, MinD,
and MinE (3, 6, 7). In the absence of the Min system, FtsZ rings
can form either at midcell or in the nucleoid-free regions at
either of the cell poles (8). Polar divisions are nonproductive as
they lead to the formation of chromosomeless minicells and
multinucleate filaments.
MinC and MinD associate to form an indiscriminate division
inhibitor whose activity is restricted to polar sites in E. coli by
the action of MinE (6). Studies of GFP1-labeled Min proteins
from the Gram-negative bacteria E. coli and Neisseria gonor-
rhoeae have revealed that they undergo a remarkable pole-to-
pole oscillation that causes the time-averaged concentration of
the MinCD division inhibitor to be lowest at midcell (9–15).
This makes midcell the preferred site for construction of an
FtsZ ring. In contrast, Bacillus subtilis and most other Gram-
positive bacteria lack the MinE protein that promotes MinCD
oscillation in E. coli. Instead, in B. subtilis, the MinCD complex
is anchored at the cell poles by DivIVA where it remains
throughout the cell cycle until a late stage in assembly of the
division apparatus when it is piloted to the nascent division
site (16–18).
MinD is a peripheral membrane protein (19), and its associ-
ation with the inner membrane is a prerequisite for subsequent
membrane recruitment of MinC (and MinE in E. coli). MinD is
a member of the ParA superfamily of ATPases that are char-
acterized by a deviant Walker A motif (19–22). The ATPase
activity of MinD provides the driving force for oscillation of the
Min proteins in E. coli; this activity is stimulated by MinE but
only in the presence of phospholipids (23–25). In vitro, in the
presence of ATP and phospholipid vesicles, MinD forms un-
branched protofilaments and filament bundles (25) as well as
tubes that appear to comprise a helical array of MinD mole-
cules (24). However, in live E. coli cells, MinD appears to be
organized into extended coiled structures that wind around the
inner membrane, with each coil presumed to consist of bundled
protofilaments (26).
The mechanism by which MinD associates with the inner
membrane proved enigmatic for more than a decade. However,
it was recently demonstrated that MinD is targeted to the
membrane by a short C-terminal motif (27, 28) that we refer to
as the membrane targeting sequence or MTS. We postulated
that this motif, which is conserved across phyla, forms a short
amphipathic -helix that mediates a direct interaction between
MinD and membrane phospholipids (27). However, this raises
a number of fundamental questions. How does the MTS recog-
nize biological membranes with different phospholipid compo-
sition? How can the MTS facilitate permanent membrane as-
sociation of B. subtilis MinD (BsMinD) but allow for rapid
cycles of membrane attachment-detachment in the case of E.
coli MinD (EcMinD)? Can the MTS function as an autonomous
membrane-targeting motif?
In this study, we show that the MinD MTS interacts directly
with lipid bilayers as an amphipathic helix, and that it can
function as a transplantable membrane-targeting motif. More-
over, we provide evidence that the phospholipid preference and
membrane affinity of each MTS has been “tuned” to its specific
role in different bacteria. We propose a new model to describe
how the MTS is coupled to ATP binding to regulate the revers-
ible membrane association of EcMinD during its oscillation
cycle.
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EXPERIMENTAL PROCEDURES
Peptide Synthesis—Peptides corresponding to residues 256–270 of
EcMinD (EcMTS256–270), EcMTS256–270 with an L267E mutation
(EcMTSL267E), residues 248–268 of BsMinD (BsMTS248–268), and
BsMTS248–268 with a randomized amino acid sequence (IKVSVFNES-
RAEFGLKQGMKM; BsMTSscramble) were synthesized using Fmoc (N-
(9-fluorenyl)methoxycarbonyl) solid phase peptide synthesis by Auspep
(Victoria, Australia). The C terminus of these peptides corresponds to
the C terminus of the native MinD proteins. The N terminus of the
peptides was acetylated to avoid introduction of a non-native charge
that would be unfavorable to helix formation (29). Correct products
were verified by electrospray mass spectrometry then purified using
reverse-phase high performance liquid chromatography. The stock con-
centration of each peptide for circular dichroism (CD) experiments was
determined by amino acid analysis.
Preparation of Small Unilamellar Vesicles (SUVs)—Chicken egg
phosphatidylcholine (PC) and phosphatidylglycerol (PG), bovine heart
cardiolipin (CL), and E. coli phosphatidylethanolamine (PE) were pur-
chased from Avanti Polar Lipids (Alabaster, AL). SUVs were prepared
as described previously (30) with minor modifications. Briefly, lipids in
CHCl3 were mixed at the desired ratio in glass vials and dried under
argon before further drying under vacuum. The dried lipids were rehy-
drated for 1 h at ambient temperature in CD buffer (1 mM NaH2PO4, 50
mM NaF, pH 7.4) to a final concentration of 10 mg ml1, before soni-
cating for 20–30 min in a bath sonicator (Fisher) until the solution
became clear. SUVs were used for CD experiments on the day they
were prepared.
CD Spectropolarimetry—Far-UV CD spectra were acquired at 25 °C
on a Jasco J-715 spectropolarimeter (Jasco, Easton, MD). Peptide and
lipid samples were mixed thoroughly in CD buffer in a 0.5-mm path-
length quartz cuvette (Hellma, New York). The peptide:SUV molar
ratio was at least 1:50. Spectra were the average of 9 scans acquired
using a scan rate of 20 nm min1 and a response time of 8 s. Background
signal (buffer only or lipid only) was subtracted from the spectra before
expressing values as mean residue molar ellipticity (, degrees cm2
dmol1). The percent -helix of each peptide was estimated from the CD
spectra according to the following equation (31, 32),
fh  222/222 ik/N (Eq. 1)
where fh is the percent helicity of the peptide, 222 is the mean residue
ellipticity of the peptide at 222 nm, 222 is the mean residue ellipticity
at 222 nm of an -helix of infinite length (39,500 degrees cm2 dmol1),
i is the number of -helices (assumed to be 1), k is a wavelength-specific
constant with a value of 2.6 at 222 nm, and N is the number of residues
in the peptide. Although Equation 1 was derived from CD spectra of
standard proteins dissolved in aqueous solution, it has been used ex-
tensively to estimate the helix content of peptides bound to lipid bilay-
ers (30, 33–35).
Construction of GFP Fusions—All GFP constructs used in this study
were placed downstream of the Para promoter and were therefore in-
ducible with arabinose. We used the gfpmut2 gene for all GFP con-
structs (36). A GFP fusion to EcMTS252–270 (GFP-EcMTS) was gener-
ated by PCR using pSLR22 (12), a pBAD33-derived plasmid encoding
Para-GFP::EcMinD, as the template and primers that incorporated
flanking XbaI/HindIII restriction sites. This allowed the excision of
EcMinD from pSLR22 and replacement by EcMTS252–270 to yield plas-
mid pTS14 encoding Para-GFP::EcMTS
252–270.
Fusions between GFP and tandem repeats of the EcMTS were con-
structed as follows. EcMTS DNA was used as a template in a PCR with
5 and 3 primers to create a fragment that encoded the following
sequence: XbaI-GGA-BglII-EcMTS-GGT-BamHI-TAG-HindIII. This
fragment was digested with XbaI/HindIII and inserted into XbaI/Hin-
dIII-cut pSLR22, yielding a plasmid (pSLR91) that expressed GFP
fused at the C terminus to the augmented EcMTS fragment SRGRS-
FIEEEKKGFLKRLFGGGGS (the native EcMTS sequence, correspond-
ing to residues 255–270, is underlined). pSLR92 was created by cutting
the same PCR fragment with XbaI/BamHI, and ligating it to XbaI/
BglII-digested pSLR91. This plasmid expresses a tandem repeat of the
EcMTS fused to the C terminus of GFP (i.e. a C-terminal FIEEEKKG-
FLKRLFGGGGS sequence is added to the fusion protein encoded by
pSLR91). An iteration of the process using pSLR92 as the backbone
produced pSLR93. Thus pSLR91, -92, and -93 express GFP fused to 1,
2, and 3 repeats of EcMTS255–270, respectively, with each repeat sepa-
rated by a Gly-Gly-Ser linker.
BsMTS248–268 was obtained by PCR using pTS26 (which encodes the
full-length B. subtilis minD gene) as template (27) and 5 and 3 primers
incorporating XbaI and PstI restriction sites, respectively. This con-
struct was then ligated into an XbaI/PstI-digested pTS26 to yield plas-
mid pCLH1 in which BsMTS248–268 is encoded as an in-frame fusion to
the C terminus of GFP (GFP::BsMTS). GFP-EcMinC-BsMTS was con-
structed as follows: PCR was used to generate BsMTS248–268 with
flanking 5-SacI and 3-HindIII sites, and EcMinC incorporating 5-
XbaI and 3-SacI sites. The two products were ligated into XbaI/Hin-
dIII-digested pTS14 to yield pCLH2 encoding EcMinC-BsMTS248–268
appended to the C terminus of GFP. A triglycine linker was included
between EcMinC and BsMTS248–268 to allow for torsional flexibility. A
similar strategy was used to construct GFP-JunLZ-EcMTS256–270
(pTS37) and GFP-JunLZ (pTS38). Briefly, the leucine zipper domain of
the human transcription factor c-Jun (JunLZ) was generated by PCR
using a plasmid encoding a homodimerization-enhanced JunLZ mutant
(A298I) as template (37). The resulting PCR product incorporated
flanking 5-XbaI and 3-PstI sites. This PCR product, along with a
PCR-generated EcMTS256–270 construct incorporating 5-PstI and 3-
HindIII sites, was then ligated into pTS14 as described above.
Fluorescence Microscopy—Visualization of GFP fusion constructs
was performed exactly as described previously (27) using the E. coli
host strain PB114 (6) that contains a deletion of the minB operon.
RESULTS
The MinD MTS Becomes Helical Upon Interaction with Lipid
Bilayers—We recently proposed that the MinD MTS interacts
directly with lipids as an amphipathic helix such that residues
on the hydrophobic face insert into the bilayer, whereas cati-
onic residues on the polar face of the helix interact preferen-
tially with the head groups of anionic phospholipids (27). To
test this hypothesis, we used CD spectropolarimetry to exam-
ine the ability of peptides encompassing the MTS of E. coli and
B. subtilis MinD to interact directly with lipid bilayers present
in the form of SUVs.
In the absence of lipids, both the EcMTS256–270 and
BsMTS248–268 peptides exhibited CD spectra with a single min-
imum at 200 nm that is characteristic of a random coil (Fig. 1,
A and C, respectively). That is, in the absence of lipid bilayers,
neither the E. coli nor the B. subtilis MTS peptides exhibit any
stable secondary structure. This is consistent with the obser-
vation that the C-terminal 30 residues of Archaeoglobus fulgi-
dus MinD are highly disordered when the protein is crystal-
lized in the absence of lipids (38).
We initially examined the interaction of MTS peptides with
SUVs containing a mixture of lipids (70% PE, 20% PG, 10% CL)
that approximated the known phospholipid ratio in the E. coli
inner membrane (39, 40); we refer to these as “wild-type” SUVs
(WT-SUVs). Addition of WT-SUVs to the EcMTS256–270 peptide
caused a significant alteration in the CD spectrum; the mini-
mum at 202 nm was slightly blue-shifted to 204 nm, and the
minimum at 222 nm became more pronounced (Fig. 1A). This
indicates that the EcMTS256–270 peptide interacts directly with
lipid bilayers, and the enhanced intensity of the peak at 222 nm
indicates that this interaction causes the MTS to become at
least partially helical. Similar random coil 3 helix transitions
in the presence of phospholipid bilayers (41) have been re-
ported for the membrane-targeting sequences of the mamma-
lian GTPase RGS4 (30) and the E. coli enzyme IIAGlucose (42).
The ellipticity at 222 nm indicates that the EcMTS256–270 pep-
tide is, on average, 35–40% helical, which corresponds to about
1.5 helical turns (5–6 residues).
We previously showed that mutating Leu267 to Glu, which
interrupts the hydrophobic surface of the putative MTS helix
by introducing a charged residue (see helical wheel in Fig. 1B),
resulted in EcMinD no longer being targeted to the membrane
(27). A peptide incorporating this mutation (EcMTSL267E) is
unstructured both in the absence of lipids and in the presence
of WT-SUVs (Fig. 1B). We conclude that the amphipathic na-
ture of the MTS helix is critical for its interaction with lipids.
Addition of WT-SUVs to the BsMTS248–268 peptide caused a
more dramatic alteration in the CD spectrum than observed
with the EcMTS256–270 peptide; the minimum at 200.5 nm was
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significantly blue-shifted to 207.5 nm, and the minimum at 222
nm became much more pronounced (Fig. 1C). The helicity
calculated from the ellipticity at 222 nm is 60%; this corre-
sponds to about 3.5 helical turns (12–13 residues), which is the
predicted size of the B. subtilis MTS (27). A peptide containing
a scrambled version of the BsMTS sequence (BsMTSscramble)
was unstructured both in the absence of lipids and in the
presence of WT-SUVs (data not shown). This indicates that
the specific sequence of residues in the MTS, and not just the
properties of the amino acid side chains, is critical for mem-
brane binding.
We conclude that both the E. coli and B. subtilis MTS inter-
act directly with phospholipid bilayers as amphipathic -heli-
ces. The percent helix calculated using Equation 1 should be
considered only an approximation of the absolute helicity of
each MTS peptide. However, the substantial difference in the
estimated helicities of the EcMTS256–270 and BsMTS248–268
peptides in the presence of WT-SUVs is nonetheless real as
evidenced by the marked difference in intensity of the charac-
teristic -helical signature at 222 nm in the CD spectra of the
peptides mixed with SUVs.
There are several possible interpretations of this apparent
difference in helicity. First, it might indicate a significant dif-
ference in the length of the helices formed by the EcMTS and
BsMTS peptides when they bind lipid bilayers. We think this
interpretation is unlikely, as the apparent helix content of the
EcMTS256–270 peptide when bound to SUVs is only1.5 helical
turns according to Equation 1, and we are unaware of any
previously documented interaction between such a small helix
and lipid membranes. The alternative explanation that we
favor is that the helices formed by the BsMTS and EcMTS
peptides are of similar size and that the more dramatic CD
spectral changes observed for the BsMTS248–268 peptide indi-
cate that it binds biological membranes with higher affinity
than the EcMTS256–270 peptide. The observed CD signal is an
average over the acquisition time of the experiment, and hence
it represents the time- and population-weighted average of the
CD signal from the free (random coil) and bound (partly helical)
peptide. If we assume that the EcMTS and BsMTS peptides
form similar sized helices in the lipid-bound state, but the
BsMTS has significantly higher affinity for SUVs than the
EcMTS, then the CD spectrum of BsMTS248–268 will be
weighted more toward the CD signature of the bound peptide
and it will appear to be more -helical than EcMTS256–270, as
we observed experimentally. Thus, although other interpreta-
tions are possible, we take the CD spectral changes observed
when the MTS peptides were incubated with SUVs as an indi-
cation that the BsMTS has higher affinity for phospholipid
bilayers.
Each MTS Is Tuned for Its Cognate Membrane Surface—
Based on the preponderance of cationic residues on the polar
face of the MTS helix (see helical wheels in Fig. 1, A and C) we
hypothesized that the E. coli and B. subtilis MTSs might pref-
erentially interact with negatively charged phospholipids such
as PG and CL (27). Consistent with this hypothesis, it was
recently demonstrated that full-length EcMinD binds prefer-
entially to liposomes containing anionic phospholipids (43). To
test whether this property of MinD resides in the MTS, we
monitored the ability of the EcMTS and BsMTS peptides to
bind SUVs with a constant amount of PE (70%) but varying
amounts of the anionic phospholipids PG and CL.
First, we examined whether anionic phospholipids are essen-
tial for MTS binding by replacing them entirely with the zwit-
terionic phospholipid PC. In marked contrast to the results
obtained with WT-SUVs, the random coil CD spectrum of the
EcMTS256–270 and BsMTS248–268 peptides was essentially un-
altered by the addition of SUVs composed entirely of the zwit-
terionic phospholipids PE (70%) and PC (30%) (compare black
and green traces in Fig. 2, A and B). In other words, these
peptides do not interact with zwitterionic SUVs. We conclude
that the E. coli and B. subtilis MTS can only interact with
biological membranes containing anionic phospholipids.
Given the markedly different phospholipid composition of
the cell membranes of E. coli and B. subtilis, we wondered
whether their respective MinD MTSs, despite their small size
(8–12 residues), might encode preferential interactions with
different anionic phospholipids. Remarkably, the BsMTS248–268
peptide exhibited a distinct preference for PG over CL. This
was demonstrated by the observation that PG-SUVs containing
70% PE, 30% PG induced a much stronger CD signal for this
peptide than CL-SUVs comprised of 70% PE, 30% CL (compare
the blue and red traces in Fig. 2B). The induced helicity, cal-
culated from the ellipticity at 222 nm, was 60% for the
BsMTS248–268 peptide in the presence of PG-SUVs versus
40% in the presence of CL-SUVs. We conclude that the
BsMTS interacts preferentially with biological membranes con-
taining PG lipids.
In contrast to the results obtained with the B. subtilis MTS,
the EcMTS256–270 peptide interacted equally well with PG- and
CL-SUVs. The helicity induced by both types of SUVs (35–40%,
see Fig. 2A) was not significantly different to the helicity in-
duced by WT-SUVs (35–40%, see Fig. 1B) that contained a
FIG. 1. Far-UV circular dichroic spectra of EcMTS256–270 (A), EcMTSL267E (B), and BsMTS248–268 (C) peptides in the absence () and
presence (E) of WT-SUVs. The SUV:peptide molar ratio was 50:1. Peptide sequences are given above the spectra with the minimal MTS (27)
highlighted in reverse type. Note that the N termini of the peptides were acetylated (Ac). The MTS regions are displayed on the spectra as helical
wheels, with hydrophobic and charged residues indicated by black and gray circles, respectively. MRE is the mean residue ellipticity in units of
degrees cm2 dmol1.
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mixture of PG and CL. We conclude that the EcMTS interacts
preferentially with bilayers containing anionic phospholipids,
but it has no particular preference for PG or CL.
The MinD MTS Is a Transplantable Membrane Targeting
Motif—We previously showed that membrane localization of
both EcMinD and BsMinD in an E. coli min strain was de-
pendent on the MTS (27). Deletion of as few as three C-termi-
nal residues in the case of EcMinD or five residues in the case
of BsMinD, as well as perturbation of the amphipathicity of the
MTS helix, was sufficient to abrogate MinD localization (27).
This indicates that the MTS is necessary, but not necessarily
sufficient, for membrane localization of MinD. It was recently
reported that GFP was not localized to the membrane when the
C-terminal 40 residues of EcMinD were appended to its N or C
terminus (28), suggesting that other regions of EcMinD may
also be involved in its association with the inner membrane.
To further explore whether the MinD MTS could act as a
transplantable membrane targeting motif, we examined the
ability of both the BsMTS and EcMTS to target GFP to the
membrane of the E. coli min strain PB114. We showed pre-
viously that GFP alone is uniformly distributed in the cyto-
plasm of these cells (27). Remarkably, when the C-terminal 21
residues of BsMinD were attached to the C terminus of GFP,
the fusion protein was localized exclusively to the cell periph-
ery, indicative of membrane association (Fig. 3A). We also
examined whether the BsMTS could target EcMinC to the cell
membrane. MinC is the proximal inhibitor of E. coli cytokinesis
(44) but it is only active when recruited to the membrane by
MinD (45). Whereas GFP-EcMinC was previously shown to be
cytoplasmic in E. coli strain PB114 (10), we found that a GFP-
EcMinC-BsMTS fusion protein was localized exclusively to the
cell periphery in this strain (Fig. 3B). Thus, the 21-residue
BsMTS is capable of targeting proteins of at least the size of the
GFP-MinC fusion protein to the cell membrane. We conclude
that the BsMTS is an autonomous and transplantable mem-
brane targeting motif.
Whereas strain PB114 normally displays a classical “mini-
celling” phenotype (i.e. a mixture of normal-length cells, short
filaments, and minicells) because of deletion of the minB
operon (6), we found that expression of GFP-EcMinC-BsMTS
caused the cells to become highly filamentous, indicative of a
general block to septation (Fig. 3B). Thus, recruitment of Ec-
MinC to the membrane using the BsMTS causes the cell divi-
sion inhibitory function of MinC to become activated even in
the absence of MinD. It was recently proposed that, in addition
to recruiting MinC to the membrane, EcMinD specifically tar-
gets MinC to nascent septal complexes (46). However, the fact
that MinC completely blocks septation when recruited to the
membrane in a MinD-independent manner suggests that
MinD-mediated targeting of MinC to septal complexes is not
essential for activation of its function.
In contrast to the results obtained with BsMTS, GFP re-
mained diffusely distributed in the cytoplasm when the C-
terminal 19 residues of EcMinD were appended to its C termi-
nus (Fig. 3C). This result supports our conclusion from the CD
experiments that the EcMTS has a weaker affinity for phos-
pholipid bilayers than the BsMTS. This raises the obvious
conundrum of how EcMinD remains stably attached to mem-
brane prior to MinE-induced ATP hydrolysis. The experiment
in which the EcMTS was appended to GFP indicates that a
single EcMTS does not provide sufficient affinity for stable
attachment to lipid bilayers. However, a recent report that
MinD undergoes an ATP-dependent dimerization led to the
suggestion that the resulting bivalent MTS might have signif-
icantly enhanced affinity for the membrane (28), because bind-
ing of the second MTS to the membrane would effectively be an
intramolecular association.
We tested this hypothesis in two ways. First, we examined
the localization of a construct in which a leucine zipper motif
was inserted between the C terminus of GFP and EcMTS256–270.
To ensure efficient dimerization of this GFP construct, we used
an A298I mutant of the c-Jun leucine zipper that was previ-
ously shown to form more stable homodimers than the native
sequence (37). A Gly-Gly-Gly linker was inserted between the
leucine zipper and EcMTS-encoding fragment to ensure that
the orientation of the MTS was not influenced by the leucine
zipper coiled coil. GFP remained cytoplasmic when tagged with
just the leucine zipper motif (Fig. 3D), but the bivalent EcMTS
construct efficiently targeted GFP to the membrane (Fig. 3E).
In a complementary experiment, we tagged the C terminus of
GFP with a tandem array of 2 or 3 copies of EcMTS255–270. Both
the GFP-(EcMTS)2 (Fig. 3F) and the GFP-(EcMTS)3 constructs
(data not shown) were mainly localized to the cell periphery.
We conclude that a multivalent, but not a monovalent, EcMTS
can associate stably with the E. coli cell membrane. Interest-
FIG. 2. Far-UV circular dichroic spectra of EcMTS256–270 (A)
and BsMTS248–268 (B) peptides in the absence of SUVs (black)
and presence of CL-SUVs (70% PE, 30% CL, red), PG-SUVs (70%
PE, 30% PG, blue), and SUVs composed entirely of zwitterionic
phospholipids (70% PE, 30% PC, green). The SUV:peptide molar
ratio was at least 50:1 in all cases. MRE is the mean residue ellipticity
in units of degrees cm2 dmol1.
FIG. 3. Fluorescence micrographs showing localization in
E. coli min strain PB114 of GFP tagged at the C terminus with
various BsMTS and EcMTS constructs. Cartoons of each construct
are shown below the corresponding micrograph. JunLZ is a homodimer-
ization-enhanced mutant of the leucine zipper motif from the c-Jun
transcription factor (37). See text for details.
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ingly, the peripheral localization was not as discrete for the
tandem GFP-(EcMTS)n constructs as we observed with the
dimeric GFP-JunLZ-EcMTS256–270 protein. This suggests that
the affinity of the EcMTS-membrane interaction may depend
not only on the valency of the EcMTS, but also on the relative
orientation of the MTSs in multivalent constructs.
DISCUSSION
The Molecular Basis of MinD Membrane Localization—It
was recently shown that membrane localization of MinD re-
quires a C-terminal MTS that is conserved across Archaea,
eubacteria, and chloroplasts (27, 45). In this study, we con-
firmed the hypothesis (27) that the MTS interacts directly with
membrane phospholipids as an amphipathic helix, with a dis-
tinct preference for anionic phospholipids. Moreover, we dem-
onstrated that the MTSs from different bacteria interact pref-
erentially with different types of anionic phospholipids, a
remarkable conclusion given the small size of this motif (8–12
residues). This observation makes teleological sense, because
the membrane composition of bacteria can vary significantly.
Thus, we found that while the EcMTS interacts preferentially
with anionic phospholipids, it does not distinguish between CL
and PG, consistent with the observation that there is only
slightly less CL (5–10% total phospholipid) than PG (20%) in
the E. coli inner membrane (39, 40). In contrast, we found that
the BsMTS has a distinct preference for PG over CL, consistent
with the fact that there are significant levels of PG (16% of total
phospholipid) and lysyl-PG (2–3%) but hardly any CL (1%) in
B. subtilis cell membranes (47). Thus, the polar surface of each
MTS -helix appears to have been evolutionarily tuned for inter-
action with specific phospholipids that are present in the inner
membrane of the bacterium in which it resides. In this respect, it
will be interesting in future studies to examine the lipid prefer-
ences of the MinD-MTSs from Archaea, whose membranes have
a very different lipid composition to eubacteria (48). However,
determination of the high-resolution structure of an MTS-
phospholipid complex will probably be critical for understanding
the molecular basis of MTS lipid preference.
MTS Affinity Is Tuned for Different Biological Roles—Why
does a monovalent MTS from BsMinD appear to be functionally
autonomous while that from EcMinD is not? The answer might
lie in the relative membrane affinities of the two MTSs, which
in turn is likely related to the quite different localization pat-
terns and biological roles of E. coli and B. subtilis MinD.
BsMinD does not oscillate; it remains anchored at the cell poles
by DivIVA until it is recruited to the nascent septum at a late
stage in assembly of the division machinery (16, 18). Thus,
BsMinD appears to remain permanently attached to the cell
membrane throughout the cell cycle. We suggest that the
BsMTS has been tuned to have very high affinity for phospho-
lipid bilayers to facilitate the persistent association of BsMinD
with the cell membrane. As demonstrated in this study, the
intrinsically high affinity of the BsMTS for lipid bilayers en-
ables it to behave as a transplantable membrane targeting
motif that should prove to be a useful experimental tool for
recruiting proteins to the cell membrane.
In contrast to the B. subtilis protein, EcMinD undergoes a
rapid pole-to-pole oscillation that persists throughout the cell
cycle. This oscillation necessitates rapid cycles of membrane
association-dissociation (27). ATP binding promotes associa-
tion of MinD with the membrane, whereas MinE-induced ATP
hydrolysis leads to release of MinD from the bilayer (23–25,
45). We postulate that an MTS with very high affinity for the
bilayer would be counterproductive to such rapid attachment-
detachment cycles. Rather, we suggest that the EcMTS is
tuned for moderate membrane affinity so that EcMinD can be
easily detached by MinE-induced ATP hydrolysis at the appro-
priate time in the oscillation cycle.
A Model for the Reversible Membrane Association of Ec-
MinD—What is the mechanism that regulates the reversible
association of the EcMTS with the cytoplasmic surface of the
inner membrane? We previously proposed, based on analogy
with the ARF1 GTPase (49), that the hydrophobic face of the
MTS helix associates with the globular core of MinD when the
protein is in the ADP or nucleotide-free form, thus precluding
association with the membrane. In this model, ATP binding
induces a conformational change in MinD that exposes the
FIG. 4. The “zipper” or cooperative polymerization model of MinD membrane association-dissociation. A, nucleotide-free EcMinD is
monomeric and therefore has a monovalent MTS. The monovalent MTS has only moderate membrane affinity and consequently MinD is largely
cytoplasmic. B, binding of ATP causes EcMinD to polymerize cooperatively on the membrane; this could be preceded by dimerization or nucleation
into short filaments prior to membrane attachment. As more MinD molecules attach to the growing, or plus, end of the MinD polymer, the MTS
becomes increasingly multivalent and its affinity for the membrane increases. Thus, the MinD polymer is stably attached to the membrane bilayer.
C, we propose that MinE first caps the plus end of the filament and prevents further growth. Second, MinE stimulates ATP hydrolysis in the MinD
monomer at the plus end of the filament, thereby abolishing lateral associations (indicated by the horizontal black bars) between it and the residual
MinD polymer. Thus, the terminal MinD molecule is converted to a monomer with a monovalent MTS, and consequently it is more likely to
dissociate from the membrane than remain attached. Continued MinE-induced ATP hydrolysis at the plus end of the filament eventually results
in complete depolymerization.
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MTS helix and promotes association with the bilayer (27). In a
variant of this model, it was proposed that the conformational
change might be caused by ATP-induced dimerization of MinD,
which would result in exposure of a bivalent MTS with en-
hanced affinity for the membrane (22, 28).
There are two problems with these models. First, they are
difficult to reconcile with the observation that the C-terminal
30 residues of A. fulgidus MinD, which encompass the MTS,
are structurally disordered when the protein is crystallized in
the absence of nucleotide and lipids (38); that is, the crystal
structure argues against any model in which membrane asso-
ciation is abrogated by a direct interaction between the MTS
and the globular core of MinD. Second, although ATP-induced
dimerization has been reported for E. coli MinD in vitro (28,
45), it does not occur under all conditions.2,3 Moreover, analyt-
ical ultracentrifugation data indicate that the dimerization of
N. gonorrhoeae MinD may be nucleotide-independent (50),
which argues that ATP-induced dimerization does not regulate
membrane attachment of MinD in this organism.
We propose an alternative mechanism for the reversible
membrane association of EcMinD that obviates both of these
problems. In this model, which we refer to as the cooperative
polymerization or zipper model (Fig. 4), the ADP and nucleoti-
de-free forms of MinD are monomeric and hence possess a
monovalent MTS that has only moderate affinity for the mem-
brane. Thus, the ADP and nucleotide-free forms of MinD will be
in dynamic equilibrium between the membrane and cytoplasm
but the equilibrium will be heavily weighted toward the cyto-
plasmic population (Fig. 4A). As shown in this study, the MTS
will be unstructured in the cytoplasmic pool of MinD and hel-
ical in the membrane-bound population. The crux of this model
is that ATP-binding promotes cooperative polymerization of
MinD on the membrane. That is, association of the ATP-bound
form of MinD with the membrane induces cooperative polym-
erization of the protein that converts a monovalent MTS into a
highly multivalent MTS. The multivalent MTS thus acts like a
zipper that grows and attaches to the membrane as MinD
polymerizes and thus further stabilizes the membrane-bound
MinD polymer (Fig. 4B). Thus, ATP-induced polymerization of
EcMinD converts a monovalent MTS with weak membrane
affinity into a polyvalent MTS with very high membrane
affinity.
The MinD polymer is believed to nucleate at one of the cell
poles and grow toward midcell (26, 51). MinE probably regu-
lates MinD polymer length in at least two ways. We suggest
that MinE initially “caps” the medial edge, or plus end, of the
filament to block further polymer growth. This is analogous to
the proposed role of SulA in rapidly blocking FtsZ polymer
growth by capping preformed protofilaments (52). The absence
of MinE rings and the longer than normal MinD polar zones
seen in cells expressing a D45A/V49A MinE mutant (51) sug-
gests that this mutant might be defective in the proposed
filament capping function. Second, binding of MinE at the
medial edge of the growing MinD polymer is thought to induce
ATP hydrolysis at the tip of the MinD filament (23, 25); in the
zipper model, this releases contact between the terminal MinD
monomer, which is now in the ADP form, and the rest of the
polymer. Thus the MinD monomer at the plus end of the
filament dissociates from the membrane because the ADP form
of the protein is not competent to polymerize and therefore its
affinity for the membrane resides in a single MTS. In contrast,
the rest of the MinD polymer remains stably attached by the
polyvalent MTS zipper.
An interesting question for future studies is why MinE ap-
pears to bind primarily at the medial edge of the MinD fila-
ment. We presume that the MinD polymer, like eukaryotic
actin and tubulin, is intrinsically asymmetric such that MinE
can only bind to the plus end. It is well established that some
proteins bind exclusively to the plus end of microtubules (53)
and that several capping proteins (e.g. CapZ and gelsolin) bind
exclusively to the barbed end of actin filaments (54). Strong
evidence that the MinD polymer is polar comes from recent in
vitro experiments indicating that MinE causes fraying at only
one end of MinD protofilaments (25).
The zipper model is supported by several lines of evidence.
First, a number of studies have demonstrated that EcMinD
assembles on lipid bilayers with positive cooperativity (23, 43)
as required by the zipper model. Second, in agreement with the
crystal structure of A. fulgidus MinD, the zipper model does not
require the MTS to be shielded from the membrane or present
in some alternative conformation in the ADP and nucleotide-
free forms of MinD; membrane association simply depends on
the valency of the MTS that in turn is determined by the level
of MinD polymerization. Third, as demonstrated in this study,
bivalent and trivalent EcMTSs are sufficient to target GFP to
the E. coli membrane, whereas a monovalent EcMTS is not.
Thus, as predicted by the zipper model, increased MTS valency
leads to enhanced membrane affinity.
The reported ATP-dependent dimerization of EcMinD has
been taken to indicate that MinD-ATP initially associates with
the membrane as a dimer (28, 45). However, the observation
that ATP-MinD oligomerizes in vitro in the absence of lipids to
form short, thin protofilaments (25) argues that short filaments
rather than dimers most likely nucleate the cooperative assem-
bly of MinD on the membrane. Although the central tenets of
the zipper model do not depend on whether the basic unit of the
membrane-bound MinD polymer is a monomer, dimer, or short
filament, it will be important in future studies to determine
whether dimerization is an essential prerequisite for coopera-
tive polymerization of MinD on the membrane.
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Note Added in Proof—Following acceptance of this manuscript, a
complementary study was published that provides further experimen-
tal support for our proposal that the MinD membrane targeting se-
quence interacts with lipid bilayers as an amphipathic helix (Zhou, H.,
and Lutkenhaus, J. (2003) J. Bacteriol. 185, 4326–4335). However, the
two studies propose different molecular mechanisms for the reversible
membrane association of E. coli MinD.
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